What are the major opportunities in the non-alcoholic steatohepatitis biomarkers market? What are the strategies for the non-alcoholic steatohepatitis biomarkers market?

For detailed insights on the major opportunities and strategies in the non-alcoholic steatohepatitis biomarkers market, Read More

How does the non-alcoholic steatohepatitis biomarkers market relate to the overall economy and other similar markets?

For detailed insights on non-alcoholic steatohepatitis biomarkers market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the non-alcoholic steatohepatitis biomarkers market growth? SWOT analysis of the non-alcoholic steatohepatitis biomarkers market.

For detailed insights on the key dynamics influencing the non-alcoholic steatohepatitis biomarkers market growth and SWOT analysis of the non-alcoholic steatohepatitis biomarkers industry, Read More

Non-Alcoholic Steatohepatitis Biomarkers Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Non-Alcoholic Steatohepatitis Biomarkers Market Report 2026

Name: Non-Alcoholic Steatohepatitis Biomarkers Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types), By Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies), By End Use (Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-Alcoholic Steatohepatitis Biomarkers Market Overview

• Non-Alcoholic Steatohepatitis Biomarkers market size has reached to $1.68 billion in 2025

• Expected to grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 22%

• Growth Driver: Rising Liver Cancer Prevalence Fuels Expansion Of Non-Alcoholic Steatohepatitis Biomarkers Market

• Market Trend: Innovative Biomarker-Based Test Receives FDA Breakthrough Designation for Fibrosis Assessment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Non-Alcoholic Steatohepatitis Biomarkers Market?

Non-alcoholic steatohepatitis (NASH) is a type of liver inflammation and damage caused by a build-up of fat in the liver. NASH biomarkers are used as diagnostic tools to assess the severity of non-alcoholic steatohepatitis and to assess liver damage. This damages the liver cells and inflames the liver, which can result in cirrhosis (liver scarring) and liver failure. Biomarkers refer to a particular quality that can be tested to reveal pathogenic processes, healthy biological processes, or reactions to exposure or treatment.

The main types of non-alcoholic steatohepatitis biomarkers include hepatic fibrosis biomarkers, serum biomarkers, oxidative stress biomarkers, apoptosis biomarkers and others. Hepatic fibrosis biomarkers refer to biomarkers for hepatic fibrosis, an overly exuberant wound healing in which excessive connective tissue develops in the liver. They are used to treat different diseases including hypertension, heart disease, high blood lipid, type 2 diabetes and obesity for use by various end-uses such as research institutes and academics, diagnostic centers, pharmaceutical companies and contract research organizations (CROs), hospitals and clinics and others.

Non-Alcoholic Steatohepatitis Biomarkers market report bar graph

What Is The Non-Alcoholic Steatohepatitis Biomarkers Market Size and Share 2026?

The non-alcoholic steatohepatitis biomarkers market size has grown exponentially in recent years. It will grow from $1.68 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 23.2%. The growth in the historic period can be attributed to increasing prevalence of metabolic disorders, rising incidence of obesity and type 2 diabetes, expansion of liver disease research programs, availability of advanced diagnostic assays, growing pharmaceutical interest in nash therapies.

What Is The Non-Alcoholic Steatohepatitis Biomarkers Market Growth Forecast?

The non-alcoholic steatohepatitis biomarkers market size is expected to see exponential growth in the next few years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 22.0%. The growth in the forecast period can be attributed to increasing investments in precision hepatology, rising demand for non-invasive diagnostic tools, expansion of biomarker-driven clinical trials, growing adoption of personalized medicine approaches, increasing focus on early-stage disease management. Major trends in the forecast period include increasing development of non-invasive diagnostic biomarkers, rising use of serum-based nash biomarkers, growing integration of ai in biomarker analysis, expansion of companion diagnostics in drug development, enhanced focus on early disease detection.

Book your 30 minutes free consultation with our research experts

Global Non-Alcoholic Steatohepatitis Biomarkers Market Segmentation

1) By Type: Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies

3) By End Use: Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses

Subsegments:

1) By Hepatic Fibrosis Biomarkers: Hyaluronic Acid, Procollagen III N-terminal Propeptide (PIIINP), Fibrosis-4 (FIB-4) Index

2) By Serum Biomarkers: Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Adiponectin

3) By Oxidative Stress Biomarkers: Malondialdehyde (MDA), 8-Isoprostane, Advanced Oxidation Protein Products (AOPP)

4) By Apoptosis Biomarkers: Caspase-3, Cytochrome c, Liver Inhibitory Protein (LIP)

5) By Other Types: Metabolomic Biomarkers, Genetic Biomarkers, Inflammatory Biomarkers

What Is The Driver Of The Non-Alcoholic Steatohepatitis Biomarkers Market?

The growing prevalence of liver cancer is expected to propel the growth of the non-alcoholic steatohepatitis biomarkers market going forward. Liver cancer refers to the development of malignant tumors within the liver and can start in the liver itself (primary liver cancer) or spread to the liver from other parts of the body (secondary or metastatic liver cancer). Non-alcoholic steatohepatitis (NASH) biomarkers are used in liver cancer for early detection, disease progression monitoring, and treatment response assessment, to provide prognostic information, and can help reduce the need for invasive procedures. For instance, in July 2025, according to the ecancer medical science, a UK-based cancer journal, earlier projections indicate that new liver cancer cases are expected to almost double from 870,000 in 2022 to 1.52 million by 2050, driven mainly by population growth and ageing, with the steepest rises anticipated in Africa. Liver cancer deaths are also projected to increase from 760,000 in 2022 to 1.37 million by 2050. Therefore, the growing prevalence of liver cancer is driving the growth of the non-alcoholic steatohepatitis biomarkers industry.

Key Players In The Global Non-Alcoholic Steatohepatitis Biomarkers Market

Major companies operating in the non-alcoholic steatohepatitis biomarkers market are Genfit SA, Prometheus Laboratories Inc., Siemens Medical Solutions USA Inc., BioPredictive, Quest Diagnostics, AstraZeneca Plc., Laboratory Corporation of America Holdings, Pfizer Inc., Bristol-Myers Squibb Company, NGM Biopharmaceuticals Inc., Gilead Sciences Inc., Perspectum Diagnostics Ltd., One Way Liver SL, Enterome SA, Echosens SA, Cisbio Bioassays SAS, Celerion Inc., Boehringer Ingelheim GmbH Inc., Exalenz Bioscience Ltd., Novartis AG, Novo Nordisk A/S, Allergan PLC., Glympse Bio, HistoIndex Pte Ltd, Cirius Therapeutics, Intercept Pharmaceuticals, Viking Therapeutics, Madrigal Pharmaceuticals, Galmed Pharmaceuticals, Immuron Ltd, Metacrine

Global Non-Alcoholic Steatohepatitis Biomarkers Market Trends and Insights

Major companies operating in the non-alcoholic steatohepatitis biomarkers market are incorporating advanced biomarker-platform technologies such as multi-analyte fibrosis-scoring assays to enhance non-invasive disease assessment and patient risk stratification. These assays measure multiple fibrosis-related proteins in a single blood sample and use an algorithm to generate a numerical score, enabling prognostic evaluation and support for identifying advanced fibrosis. For instance, in July 2023, Siemens Healthineers, a Germany-based medical-technology company, received breakthrough device designation from the US Food and Drug Administration for the Enhanced Liver Fibrosis Test, a multi-analyte fibrosis-scoring assay intended to support identification of advanced fibrosis and cirrhosis in individuals with non-alcoholic fatty liver disease, featuring a numerical score derived from three direct fibrosis biomarkers. The test supports earlier clinical evaluation of liver disease severity and reduces reliance on invasive biopsy.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Biomarkers Market?

In November 2023, Alimentiv Inc., a Canada-based clinical research organization specializing in precision-medicine and biomarker services, partnered with AcelaBio Inc. and PharmaNest Inc. to advance artificial intelligence (AI)-enabled digital pathology solutions for non-alcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH) clinical trials. With this partnership, Alimentiv aims to integrate high-throughput pathology, spatial transcriptomics, and advanced AI-based biomarker quantification into its offerings. AcelaBio Inc. is a US–based clinical research laboratory accredited by the College of American Pathologists (CAP), and PharmaNest Inc. is a US–based digital pathology and AI technology company specializing in quantitative biomarker analysis.

Regional Outlook

North America was the largest region in the non-alcoholic steatohepatitis biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-alcoholic steatohepatitis biomarkers market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Non-Alcoholic Steatohepatitis Biomarkers Market?

The non-alcoholic steatohepatitis biomarkers market consists of sales of biomarkers such as apolipoprotein A1, apolipoprotein B, leptin and adiponectin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Alcoholic Steatohepatitis Biomarkers Market Report 2026?

The non-alcoholic steatohepatitis biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-alcoholic steatohepatitis biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Non-Alcoholic Steatohepatitis Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.08 billion
Revenue Forecast In 2035	$4.6 billion
Growth Rate	CAGR of 23.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Technology, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Genfit SA, Prometheus Laboratories Inc., Siemens Medical Solutions USA Inc., BioPredictive, Quest Diagnostics, AstraZeneca Plc., Laboratory Corporation of America Holdings, Pfizer Inc., Bristol-Myers Squibb Company, NGM Biopharmaceuticals Inc., Gilead Sciences Inc., Perspectum Diagnostics Ltd., One Way Liver SL, Enterome SA, Echosens SA, Cisbio Bioassays SAS, Celerion Inc., Boehringer Ingelheim GmbH Inc., Exalenz Bioscience Ltd., Novartis AG, Novo Nordisk A/S, Allergan PLC., Glympse Bio, HistoIndex Pte Ltd, Cirius Therapeutics, Intercept Pharmaceuticals, Viking Therapeutics, Madrigal Pharmaceuticals, Galmed Pharmaceuticals, Immuron Ltd, Metacrine
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Non-Alcoholic Steatohepatitis Biomarkers Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Non-Alcoholic Steatohepatitis Biomarkers Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Non-Alcoholic Steatohepatitis Biomarkers Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Non-Alcoholic Steatohepatitis Biomarkers Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Development Of Non-Invasive Diagnostic Biomarkers

4.2.2 Rising Use Of Serum-Based Nash Biomarkers

4.2.3 Growing Integration Of Ai In Biomarker Analysis

4.2.4 Expansion Of Companion Diagnostics In Drug Development

4.2.5 Enhanced Focus On Early Disease Detection

5. Non-Alcoholic Steatohepatitis Biomarkers Market Analysis Of End Use Industries

5.1 Research Institutes And Academics

5.2 Diagnostic Centers

5.3 Pharmaceutical Companies

5.4 Contract Research Organizations

5.5 Hospitals And Clinics

6. Non-Alcoholic Steatohepatitis Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Alcoholic Steatohepatitis Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Non-Alcoholic Steatohepatitis Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size, Comparisons And Growth Rate Analysis

7.3. Global Non-Alcoholic Steatohepatitis Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Non-Alcoholic Steatohepatitis Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Alcoholic Steatohepatitis Biomarkers Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Alcoholic Steatohepatitis Biomarkers Market Segmentation

9.1. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types

9.2. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies

9.3. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses

9.4. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Hepatic Fibrosis Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hyaluronic Acid, Procollagen III N-terminal Propeptide (PIIINP), Fibrosis-4 (FIB-4) Index

9.5. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Serum Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Adiponectin

9.6. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Oxidative Stress Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Malondialdehyde (MDA), 8-Isoprostane, Advanced Oxidation Protein Products (AOPP)

9.7. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Apoptosis Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Caspase-3, Cytochrome c, Liver Inhibitory Protein (LIP)

9.8. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metabolomic Biomarkers, Genetic Biomarkers, Inflammatory Biomarkers

10. Non-Alcoholic Steatohepatitis Biomarkers Market Regional And Country Analysis

10.1. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Non-Alcoholic Steatohepatitis Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market

11.1. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Alcoholic Steatohepatitis Biomarkers Market

12.1. China Non-Alcoholic Steatohepatitis Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Alcoholic Steatohepatitis Biomarkers Market

13.1. India Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Alcoholic Steatohepatitis Biomarkers Market

14.1. Japan Non-Alcoholic Steatohepatitis Biomarkers Market Overview

14.2. Japan Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Alcoholic Steatohepatitis Biomarkers Market

15.1. Australia Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Alcoholic Steatohepatitis Biomarkers Market

16.1. Indonesia Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market

17.1. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market Overview

17.2. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Alcoholic Steatohepatitis Biomarkers Market

18.1. Taiwan Non-Alcoholic Steatohepatitis Biomarkers Market Overview

18.2. Taiwan Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Alcoholic Steatohepatitis Biomarkers Market

19.1. South East Asia Non-Alcoholic Steatohepatitis Biomarkers Market Overview

19.2. South East Asia Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Alcoholic Steatohepatitis Biomarkers Market

20.1. Western Europe Non-Alcoholic Steatohepatitis Biomarkers Market Overview

20.2. Western Europe Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Alcoholic Steatohepatitis Biomarkers Market

21.1. UK Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Alcoholic Steatohepatitis Biomarkers Market

22.1. Germany Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Alcoholic Steatohepatitis Biomarkers Market

23.1. France Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Alcoholic Steatohepatitis Biomarkers Market

24.1. Italy Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Alcoholic Steatohepatitis Biomarkers Market

25.1. Spain Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Alcoholic Steatohepatitis Biomarkers Market

26.1. Eastern Europe Non-Alcoholic Steatohepatitis Biomarkers Market Overview

26.2. Eastern Europe Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Alcoholic Steatohepatitis Biomarkers Market

27.1. Russia Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Alcoholic Steatohepatitis Biomarkers Market

28.1. North America Non-Alcoholic Steatohepatitis Biomarkers Market Overview

28.2. North America Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Alcoholic Steatohepatitis Biomarkers Market

29.1. USA Non-Alcoholic Steatohepatitis Biomarkers Market Overview

29.2. USA Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Alcoholic Steatohepatitis Biomarkers Market

30.1. Canada Non-Alcoholic Steatohepatitis Biomarkers Market Overview

30.2. Canada Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Alcoholic Steatohepatitis Biomarkers Market

31.1. South America Non-Alcoholic Steatohepatitis Biomarkers Market Overview

31.2. South America Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Alcoholic Steatohepatitis Biomarkers Market

32.1. Brazil Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Alcoholic Steatohepatitis Biomarkers Market

33.1. Middle East Non-Alcoholic Steatohepatitis Biomarkers Market Overview

33.2. Middle East Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Alcoholic Steatohepatitis Biomarkers Market

34.1. Africa Non-Alcoholic Steatohepatitis Biomarkers Market Overview

34.2. Africa Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Alcoholic Steatohepatitis Biomarkers Market Regulatory and Investment Landscape

36. Non-Alcoholic Steatohepatitis Biomarkers Market Competitive Landscape And Company Profiles

36.1. Non-Alcoholic Steatohepatitis Biomarkers Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Non-Alcoholic Steatohepatitis Biomarkers Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Non-Alcoholic Steatohepatitis Biomarkers Market Company Profiles

36.3.1. Genfit SA Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Prometheus Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Siemens Medical Solutions USA Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. BioPredictive Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

37. Non-Alcoholic Steatohepatitis Biomarkers Market Other Major And Innovative Companies

AstraZeneca Plc., Laboratory Corporation of America Holdings, Pfizer Inc., Bristol-Myers Squibb Company, NGM Biopharmaceuticals Inc., Gilead Sciences Inc., Perspectum Diagnostics Ltd., One Way Liver SL, Enterome SA, Echosens SA, Cisbio Bioassays SAS, Celerion Inc., Boehringer Ingelheim GmbH Inc., Exalenz Bioscience Ltd., Novartis AG

38. Global Non-Alcoholic Steatohepatitis Biomarkers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Biomarkers Market

40. Non-Alcoholic Steatohepatitis Biomarkers Market High Potential Countries, Segments and Strategies

40.1 Non-Alcoholic Steatohepatitis Biomarkers Market In 2030 - Countries Offering Most New Opportunities

40.2 Non-Alcoholic Steatohepatitis Biomarkers Market In 2030 - Segments Offering Most New Opportunities

40.3 Non-Alcoholic Steatohepatitis Biomarkers Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Overview Of Key Products - Product Examples

Table 2: Global Non-Alcoholic Steatohepatitis Biomarkers Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Supply Chain Analysis

Table 4: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Raw Material Providers

Table 5: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Resource Providers

Table 6: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Manufacturers (Suppliers)

Table 7: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Distributors And Channel Partners

Table 8: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Key Technologies & Future Trends

Table 9: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Trends

Table 10: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major End Users

Table 11: Global Non-Alcoholic Steatohepatitis Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Non-Alcoholic Steatohepatitis Biomarkers Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Non-Alcoholic Steatohepatitis Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Non-Alcoholic Steatohepatitis Biomarkers Market - TAM, US$ Billion, 2025

Table 15: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Hepatic Fibrosis Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Serum Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Oxidative Stress Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Apoptosis Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Non-Alcoholic Steatohepatitis Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Non-Alcoholic Steatohepatitis Biomarkers Market - Company Scoring Matrix

Table 99: Genfit SA Financial Performance

Table 100: Prometheus Laboratories Inc. Financial Performance

Table 101: Siemens Medical Solutions USA Inc. Financial Performance

Table 102: BioPredictive Financial Performance

Table 103: Quest Diagnostics Financial Performance

Table 104: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Competitive Dashboard

Table 106: Global Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 108: Global, Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 109: Global, Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), Segmentation By End Use, 2025 – 2030

List Of Figures

Figure 1: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Overview Of Key Products - Product Examples

Figure 2: Global Non-Alcoholic Steatohepatitis Biomarkers Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Supply Chain Analysis

Figure 4: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Raw Material Providers

Figure 5: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Resource Providers

Figure 6: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Manufacturers (Suppliers)

Figure 7: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Distributors And Channel Partners

Figure 8: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Key Technologies & Future Trends

Figure 9: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major Trends

Figure 10: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Major End Users

Figure 11: Global Non-Alcoholic Steatohepatitis Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Non-Alcoholic Steatohepatitis Biomarkers Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Non-Alcoholic Steatohepatitis Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Non-Alcoholic Steatohepatitis Biomarkers Market - TAM, US$ Billion, 2025

Figure 15: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Hepatic Fibrosis Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Serum Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Oxidative Stress Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Apoptosis Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Non-Alcoholic Steatohepatitis Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Non-Alcoholic Steatohepatitis Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Non-Alcoholic Steatohepatitis Biomarkers Market - Company Scoring Matrix

Figure 99: Genfit SA Financial Performance

Figure 100: Prometheus Laboratories Inc. Financial Performance

Figure 101: Siemens Medical Solutions USA Inc. Financial Performance

Figure 102: BioPredictive Financial Performance

Figure 103: Quest Diagnostics Financial Performance

Figure 104: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Non-Alcoholic Steatohepatitis Biomarkers Market, Competitive Dashboard

Figure 106: Global Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 108: Global, Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 109: Global, Non-Alcoholic Steatohepatitis Biomarkers Market Size Gain ($ Billion), Segmentation By End Use, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Epoxy Composite Market Report 2026 - Global Outlook – By Fiber Type (Glass Fiber, Carbon Fiber, Other Fiber Types), By Manufacturing Process (Lay-up, Compression Molding, Resin Injection, Resin Transfer Molding, Filament...

Debt Financing Market Report 2026 - Global Outlook – By Sources (Private, Public), By Type (Bank Loans, Bonds, Debentures, Other Types), By Duration (Short-Term, Long-Term) – Market Size, Trends, Strategies, and Forecast...

Microcarrier Market Report 2026 - Global Outlook – By Product (Equipment, Consumables), By Microcarrier Type (Cationic Microcarriers, Collagen-Coated Microcarriers, Protein-Coated Microcarriers, Untreated Microcarriers, ...

Frequently Asked Questions

How big is the Non-Alcoholic Steatohepatitis Biomarkers Market?

The Non-Alcoholic Steatohepatitis Biomarkers market was valued at $1.68 billion in 2025, increased to $2.08 billion in 2026, and is projected to reach $4.6 billion by 2030.

What is the Non-Alcoholic Steatohepatitis Biomarkers market growth?

The global Non-Alcoholic Steatohepatitis Biomarkers market is expected to grow at a CAGR of 22.0% from 2026 to 2035 to reach $4.6 billion by 2035.

Who are the key players in Non-Alcoholic Steatohepatitis Biomarkers market?

Some Key Players in the Non-Alcoholic Steatohepatitis Biomarkers market Include, Genfit SA, Prometheus Laboratories Inc., Siemens Medical Solutions USA Inc., BioPredictive, Quest Diagnostics, AstraZeneca Plc., Laboratory Corporation of America Holding

Major trend in this market includes: Innovative Biomarker-Based Test Receives FDA Breakthrough Designation for Fibrosis Assessment . For further insights on this market. request a sample here

North America was the largest region in the non-alcoholic steatohepatitis biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-alcoholic steatohepatitis biomarkers market during the forecast period.

Book your 30 minutes free consultation with our research experts

Contact Us